A core outcome set for localised prostate cancer effectiveness trials: protocol for a systematic review of the literature and stakeholder involvement through interviews and a Delphi survey

[1]  M. Usher,et al.  The United Kingdom , 2001, Migration and Integration.

[2]  S. McGuire.  World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. , 2016, Advances in nutrition.

[3]  Thomas A Kelley,et al.  International Consortium for Health Outcomes Measurement (ICHOM) , 2015, Trials.

[4]  P. Williamson,et al.  The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation. , 2015, Health technology assessment.

[5]  C. Robertson,et al.  Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation. , 2015, Health technology assessment.

[6]  Steven J Frank,et al.  Defining a standard set of patient-centered outcomes for men with localized prostate cancer. , 2014, European urology.

[7]  Carolyn M. Reilly,et al.  Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. , 2014, Journal of the National Cancer Institute.

[8]  Paula R. Williamson,et al.  Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review , 2014, PloS one.

[9]  P. Williamson,et al.  Core outcome set development: the effect of Delphi panel composition and feedback on prioritisation of outcomes , 2013, Trials.

[10]  C Fraser,et al.  The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation. , 2013, Health technology assessment.

[11]  M. O. Sharif,et al.  MOMENT – Management of Otitis Media with Effusion in Cleft Palate: protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey , 2013, Trials.

[12]  J. Leal,et al.  Economic Burden of Malignant Neoplasms in the European Union , 2012 .

[13]  Jane M Blazeby,et al.  Developing core outcome sets for clinical trials: issues to consider , 2012, Trials.

[14]  Timothy J Wilt,et al.  Radical prostatectomy versus observation for localized prostate cancer. , 2012, The New England journal of medicine.

[15]  P. Williamson,et al.  Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people , 2012, Trials.

[16]  A. Jemal,et al.  International variation in prostate cancer incidence and mortality rates. , 2012, European urology.

[17]  Deb Feldman-Stewart,et al.  Information that affects patients' treatment choices for early stage prostate cancer: a review. , 2011, The Canadian journal of urology.

[18]  Raveendhara R. Bannuru,et al.  Comparative Evaluation of Radiation Treatments for Clinically Localized Prostate Cancer: An Updated Systematic Review , 2011, Annals of Internal Medicine.

[19]  P. Royle,et al.  Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines , 2011, World Journal of Urology.

[20]  J. Grimshaw,et al.  What is an adequate sample size? Operationalising data saturation for theory-based interview studies , 2010, Psychology & health.

[21]  Douglas G Altman,et al.  The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews , 2010, BMJ : British Medical Journal.

[22]  P. Walsh,et al.  The case for open radical prostatectomy. , 2010, The Urologic clinics of North America.

[23]  N. Shah,et al.  Robotic-assisted laparoscopic prostatectomy , 2009, British Journal of Cancer.

[24]  M. Menon,et al.  Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. , 2009, European urology.

[25]  T. Wilt,et al.  Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer , 2008, Annals of Internal Medicine.

[26]  M. Boers,et al.  A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout , 2007, Annals of the rheumatic diseases.

[27]  David Gillatt,et al.  The risk of prostate cancer amongst black men in the United Kingdom: the PROCESS cohort study. , 2007, European urology.

[28]  Tom Dehn,et al.  Open Versus Laparoscopic Radical Prostatectomy , 2007 .

[29]  C. Eden.  Open versus laparoscopic radical prostatectomy. The case for laparoscopic surgery. , 2007, Annals of the Royal College of Surgeons of England.

[30]  S. Ramsey,et al.  Why do men choose one treatment over another? , 2006, Cancer.

[31]  Azeem Majeed,et al.  The ageing population of the United Kingdom and cardiovascular disease , 2005, BMJ : British Medical Journal.

[32]  E. Giannini,et al.  Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. , 2004, The Journal of rheumatology.

[33]  Yair Lotan,et al.  The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques. , 2004, The Journal of urology.

[34]  S. Moss,et al.  Rates of prostate‐specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross‐sectional study , 2004, BJU international.

[35]  G. Finnerty.  Qualitative Research Practice. A Guide for Social Science Students and Researchers , 2003 .

[36]  T. Peters,et al.  Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study). , 2003, Journal of clinical epidemiology.

[37]  Samantha Sharpe,et al.  Cancer Research UK , 2002, Nature Cell Biology.

[38]  D. Brewster,et al.  Rising incidence of prostate cancer in Scotland: increased risk or increased detection? , 2000, BJU international.

[39]  A. Partin,et al.  Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.

[40]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[41]  P. Schellhammer,et al.  Assessment of endpoints for clinical trials for localized prostate cancer. , 1997, Urology.

[42]  L. Holmberg,et al.  Planning controlled clinical trials , 1997 .

[43]  J. Oesterling,et al.  Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association. , 1995, The Journal of urology.

[44]  M. Hafermann,et al.  Radiation therapy for localized prostate cancer , 1979, Cancer.

[45]  I sabel Mortara,et al.  International Union against Cancer , 1938, Nature.

[46]  P. Williamson,et al.  The management of Otitis Media with Effusion (OME) in children with Cleft Palate: A feasibility study. (mOMEnt). , 2015 .

[47]  Peter Chang,et al.  Recommended patient-reported core set of symptoms to measure in prostate cancer treatment trials. , 2014, Journal of the National Cancer Institute.

[48]  J. Ritchie,et al.  QUALITATIVE RESEARCH PRACTICE A GUIDE FOR SOCIAL SCIENCE STUDENTS AND RESEARCHERS , 2013 .

[49]  Jacques Ferlay,et al.  GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 , 2013 .

[50]  T B Lam,et al.  Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer. , 2012, Health technology assessment.

[51]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[52]  B. Guillonneau,et al.  Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences. , 2009, European urology.

[53]  Nadeem Shaida,et al.  Open versus laparoscopic radical prostatectomy. The case for open radical prostatectomy. , 2007, Annals of the Royal College of Surgeons of England.

[54]  P. Dasgupta,et al.  A selected review and personal experience with robotic prostatectomy: implications for adoption of this new technology in the United Kingdom , 2007, Prostate Cancer and Prostatic Diseases.

[55]  L. Holmberg,et al.  Planning controlled clinical trials. Prostatic cancer. , 1997, Urology.

[56]  J. Higginson.  International Agency for Research on Cancer. , 1968, WHO chronicle.